William E. Kennard - 01 Oct 2021 Form 4 Insider Report for METLIFE INC (MET)

Role: Director
Signature: /s/ Anna Nazarenko, Authorized Signer
Issuer symbol: MET
Transactions as of: 01 Oct 2021
Net transactions value: +$37,512
Form type: 4
Filing time: 05 Oct 2021, 16:34:40 UTC
Previous filing: 16 Sep 2021
Next filing: 02 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MET	Common Stock	Award	$37,512	+600	+2%	$62.52	30,254	01 Oct 2021	Direct	F1
holding	MET	Common Stock						10	01 Oct 2021	By the MetLife Policyholder Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2	Shares held in trust under the MetLife Policyholder Trust established to hold shares of MetLife, Inc. common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney